Next Generation News and Research

RSS

Merck partners with Promega to advance 3-D cell dug discovery technologies

Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life science solutions and service leader based in Madison, Wisconsin in the US, to co-develop novel technologies that advance drug screening and discovery.

From Merck 30 Oct 2025

Fundamental challenges and cutting-edge strategies in developing new GBM CAR-T therapies

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under two years, despite standard care involving surgery, radiation, and temozolomide chemotherapy.

30 Oct 2025

Scripps Research professor wins $3.2 million grant to unravel the mysteries of type 1 diabetes

Luc Teyton, professor in the Department of Immunology and Microbiology at Scripps Research, has received a five-year, $3.2 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to help answer how type 1 diabetes manifests and develop potential therapeutics to reverse or prevent the disease.

29 Oct 2025

Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors

A systematic review published today in Psychedelics by Mr. James Gattuso and colleagues at the Florey Institute of Neuroscience and Mental Health synthesizes clinical and preclinical evidence on psilocybin's effects on obsessive-compulsive behaviors, revealing consistent therapeutic potential across human patients and validated animal models.

29 Oct 2025

AI indelibly transforms solid tumor drug development

Artificial intelligence (AI) is fundamentally reshaping the landscape of solid tumor (ST) drug development.

29 Oct 2025

Hydroxytyrosol from olives shows new promise as a brain-protective compound

This review highlights hydroxytyrosol's role as a neuroprotective agent, activating key pathways for mental and vascular health through olive-derived compounds.

29 Oct 2025

Emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder

In a peer-reviewed article published today in Brain Medicine, a European research team presents a focused review of emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder (OCD).

28 Oct 2025

Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorder

The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar disorder and pioneer novel neuromodulation-based treatment strategies.

28 Oct 2025

Using AI and citizen science for vector-borne disease surveillance

Researchers from the University of South Florida have used artificial intelligence and citizen science to identify what may be the first specimen of Anopheles stephensi - an invasive and deadly malaria-carrying mosquito - ever detected in Madagascar.

28 Oct 2025

CZI and NVIDIA collaborate to accelerate life science research through virtual cell models

Today, the Chan Zuckerberg Initiative (CZI) and NVIDIA announced an expanded collaboration to accelerate life science research by driving development and adoption of virtual cell models through tools, data, models, and benchmarks delivered through CZI's virtual cells platform (VCP).

28 Oct 2025

Scripps Research wins $4 million CIRM grant to develop novel platform for neurodevelopmental disorders

Most people are born with two functioning copies of each gene-one inherited from each parent. In many cases, having just one working copy is enough for the body to function normally.

28 Oct 2025

Fogarty Innovation and CRF unite to accelerate breakthroughs in cardiovascular medicine

After several years of close collaboration and a relationship rooted in mutual respect and shared vision, Fogarty Innovation is coming together with the Cardiovascular Research Foundation® (CRF®) to create a unified platform for advancing transformative healthcare technologies.

27 Oct 2025

Ancient DNA uncovers paratyphoid and relapsing fever among Napoleonic troops

Scientists from the Institut Pasteur have genetically analyzed the remains of former soldiers who retreated from Russia in 1812.

24 Oct 2025

Study reveals how brain activity, energy use, and blood flow interact during sleep

Findings from Mass General Brigham investigators highlight the intricate interplay of diverse physiological processes as the brain shifts from wakefulness to sleep.

24 Oct 2025

GemPharmatech collaborates with MSK Cancer Center to accelerate discovery of therapeutic antibodies

GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies.

23 Oct 2025

New technology can track beneficial bacteria after fecal microbiota transplants

Researchers at the Icahn School of Medicine at Mount Sinai and their collaborators have developed a new technology to track beneficial bacteria after fecal microbiota transplants (FMT).

22 Oct 2025

Epigenetic editing enables safer and more effective T cell therapies

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary human T cells, addressing a key manufacturing and scalability challenge in next-generation cell therapies.

21 Oct 2025

Researchers develop a novel approach to monitor CD8⁺ T cell activity over time

The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies.

21 Oct 2025

Introducing the Metrohm i-Raman NxG

Introducing the i-Raman NxG: a next-gen Raman spectrometer enhancing precision in quality control with advanced features and versatile software integration.

From Metrohm AG 21 Oct 2025

New chip restores reading ability for macular degeneration patients

A tiny wireless chip implanted in the back of the eye and a pair of high-tech glasses have partially restored vision to people with an advanced form of age-related macular degeneration. In a clinical trial led by Stanford Medicine researchers and international collaborators, 27 out of 32 participants had regained the ability to read a year after receiving the device.

21 Oct 2025

Next Generation News and Research

Merck partners with Promega to advance 3-D cell dug discovery technologies

Fundamental challenges and cutting-edge strategies in developing new GBM CAR-T therapies

Scripps Research professor wins $3.2 million grant to unravel the mysteries of type 1 diabetes

Systematic analysis reveals psilocybin's impact on obsessive-compulsive behaviors

AI indelibly transforms solid tumor drug development

Hydroxytyrosol from olives shows new promise as a brain-protective compound

Emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder

Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorder

Using AI and citizen science for vector-borne disease surveillance

CZI and NVIDIA collaborate to accelerate life science research through virtual cell models

Scripps Research wins $4 million CIRM grant to develop novel platform for neurodevelopmental disorders

Fogarty Innovation and CRF unite to accelerate breakthroughs in cardiovascular medicine

Ancient DNA uncovers paratyphoid and relapsing fever among Napoleonic troops

Study reveals how brain activity, energy use, and blood flow interact during sleep

GemPharmatech collaborates with MSK Cancer Center to accelerate discovery of therapeutic antibodies

New technology can track beneficial bacteria after fecal microbiota transplants

Epigenetic editing enables safer and more effective T cell therapies

Researchers develop a novel approach to monitor CD8⁺ T cell activity over time

Introducing the Metrohm i-Raman NxG

New chip restores reading ability for macular degeneration patients

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News